SecBot SecBot

SKYE

Skye Bioscience, Inc.
Nasdaq· Pharmaceutical Preparations· Inc. NV· CIK 0001516551 Biotech & Drug Discovery
$1.07 −0.02 (−2.29%)
Nov 16 4:00 PM ET · prev $1.09
Market cap
$4.8M
Nano cap
Median target
🔒 Subscribers only
1 year
−90.5%
from $11.20 · Nov 17
30 days
−30.4%
from $1.53
52-week range
$0.6900–11.20
−90% from high · low Nov 9
Avg volume 20D
122.2K
Nov 10 spike 1.66M
Short interest
129.3K
≈2.9% of shares · −7.8%
Days to cover
6.3
at average volume
Insider net
−$889.2K
0 buyers · 2 sellers · since Mar 31
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
13
analyzed by SecBot
SecBot read BEARISH 8 reports · 90 days
Balance 3 bearish · 0 bullish · 5 neutral oldest → newest, height = score
Avg score ·High conf. 6/8

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    2 insiders sold $889.2K.

  • InstitutionsMIXED

    Q2 2026: 2 added (0 new), 3 trimmed or exited.

  • Short sellersSTEADY

    Short interest −7.8% to 129.3K shares. 6.3 days to cover, ≈2.9% of shares.

  • TrendDOWNTREND

    31% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGADD73,800$51.1K
NORTHERN TRUST CORPDOUBLED56,327$39.1K
GROUP ONE TRADING LLCTRIM4,589$3.2K
BARCLAYS PLCNEAR_EXIT655$455.00
TD Waterhouse Canada Inc.TRIM52$35.00
GEODE CAPITAL MANAGEMENT, LLCADD277,256$170.4K
MILLENNIUM MANAGEMENT LLCTRIM258,200$158.7K
UBS Group AGDOUBLED45,762$28.1K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Sep 2025

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Sep 30, 2025HC Wainwright & Co.
INITIATE
INITIATEBuy
Aug 15, 2025Evercore ISI Group
INITIATE
INITIATEOutperform
Jun 24, 2025JMP Securities
REITERATE
REITERATEMarket Outperform
Mar 21, 2025Craig-Hallum
MAINTAIN
MAINTAINBuy
Mar 21, 2025Citizens Capital Markets
REITERATE
REITERATEMarket Outperform
Feb 28, 2025William Blair
INITIATE
INITIATEOutperform

Insider ledger

Form 4
$0
bought · 0 insiders
$889.2K
sold · 2 insiders
DateInsiderTypeValue
Sep 23, 2026
Schwab Andrew J.
Director
Sep 23, 2026
SELL$184.9K
Sep 23, 2026
Schwab Andrew J.
Director
Sep 23, 2026
SELL$7.3K
Sep 23, 2026
5AM Partners VII, LLC
10%+ Owner
Sep 23, 2026
SELL$184.9K
Sep 23, 2026
5AM Partners VII, LLC
10%+ Owner
Sep 23, 2026
SELL$7.3K
Sep 22, 2026
Schwab Andrew J.
Director
Sep 22, 2026
SELL$45.6K
Sep 22, 2026
Schwab Andrew J.
Director
Sep 22, 2026
SELL$1.8K
Sep 22, 2026
5AM Partners VII, LLC
10%+ Owner
Sep 22, 2026
SELL$45.6K
Sep 22, 2026
5AM Partners VII, LLC
10%+ Owner
Sep 22, 2026
SELL$1.8K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
129,314
shares short
-7.8%
vs prior settlement
6.3
days to cover
≈2.9%
of shares outstanding
Trading halts
Nov 10, 2026Volatility PauseResumed
Aug 21, 2026Resumption ScheduledResumed
Aug 14, 2026Volatility PauseResumed
Aug 14, 2026Resumption ScheduledResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
3 drugs tracked · Drug pipeline →
Recent

SecBot reports

13 filings · 3 press releases · 0 bullish · 5 bearish · 1 mixed · 7 neutral
All SKYE filing & press-release reports (16)